# ClinicalTrials.gov record NCT02092597

> PeptideScanner retained ClinicalTrials.gov record NCT02092597 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-02-07, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct02092597-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-02-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02092597-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02092597-exenatide-v1.json
- Content SHA-256: `03f0b3af2ecf2a18464bde34091e4bd81f5fd9feaa750aa3926e0073220d6d9d`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02092597 ([`ctg-observation-nct02092597-2018-02-07-29fd3c56a200`](#source-ctg-observation-nct02092597-2018-02-07-29fd3c56a200))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02092597 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-02-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02092597-2018-02-07-29fd3c56a200`](#source-ctg-observation-nct02092597-2018-02-07-29fd3c56a200))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02092597 at 2026-07-30T21:12:47.409Z. Its registry update date was 2018-02-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct02092597-2018-02-07-29fd3c56a200`](#source-ctg-observation-nct02092597-2018-02-07-29fd3c56a200))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02092597-2018-02-07-29fd3c56a200`](#source-ctg-observation-nct02092597-2018-02-07-29fd3c56a200))

## Sources

<a id="source-ctg-observation-nct02092597-2018-02-07-29fd3c56a200"></a>
- **ClinicalTrials.gov record NCT02092597 · retained source version 2018-02-07:29fd3c56a200129735d0b1c5f6418907fe0d937c452aec4613d6fa9f16badd25** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02092597) (`ctg-observation-nct02092597-2018-02-07-29fd3c56a200`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02092597." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02092597-exenatide-v1.json SHA-256: 03f0b3af2ecf2a18464bde34091e4bd81f5fd9feaa750aa3926e0073220d6d9d.